| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Joellen M Schildkraut | Q61822968 |
| P2093 | author name string | Melissa L Bondy | |
| Joseph L Wiemels | |||
| Margaret Wrensch | |||
| Elizabeth B Claus | |||
| Peter M Black | |||
| Lisa Calvocoressi | |||
| P2860 | cites work | Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial | Q27860743 |
| Breast carcinoma in situ: risk factors and screening patterns | Q28209206 | ||
| Epidemiology of primary brain tumors: current concepts and review of the literature | Q30501715 | ||
| Hormonal exposures and the risk of intracranial meningioma in women: a population-based case-control study | Q33246038 | ||
| Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas | Q34001907 | ||
| Changes in U.S. prescribing patterns of menopausal hormone therapy, 2001-2003. | Q34543891 | ||
| Sex steroid hormone exposures and risk for meningioma | Q35580356 | ||
| The prognostic value of progesterone receptor status in meningiomas | Q35588014 | ||
| Hormone replacement therapy in cancer survivors. | Q35850744 | ||
| Epidemiology of intracranial meningioma | Q36332389 | ||
| When is it appropriate to prescribe postmenopausal hormone therapy? | Q36493184 | ||
| Brain tumour and pregnancy | Q37136051 | ||
| The relapsing course of certain meningiomas in relation to pregnancy and menstruation | Q37150724 | ||
| Reproductive and hormonal factors and risk of brain tumors in adult females | Q38448322 | ||
| Estrogen-receptor protein in intracranial meningiomas | Q41454650 | ||
| Medical risk factors and the development of brain tumors | Q41848749 | ||
| The association between breast carcinoma and meningioma in women | Q42673268 | ||
| Association of meningioma with reproductive factors | Q43717138 | ||
| A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study | Q45064852 | ||
| Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative | Q46943209 | ||
| Expression of estrogen receptors alpha and beta in human meningiomas | Q48152972 | ||
| Expression of androgen and progesterone receptors in primary human meningiomas | Q48324680 | ||
| Risk of brain tumors associated with exposure to exogenous female sex hormones | Q48474401 | ||
| Reproductive factors and the risk of brain tumors: a population-based study in Sweden | Q48655221 | ||
| Progesterone and estrogen receptors in meningiomas: prognostic considerations. | Q50981696 | ||
| Oral contraceptives and the risk of breast cancer. | Q55035937 | ||
| Epidemiology of intracranial meningioma | Q56874837 | ||
| Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice | Q68965982 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 471-476 | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Exogenous hormone use and meningioma risk: what do we tell our patients? | |
| P478 | volume | 110 |
| Q34482713 | A pregnant female with a large intracranial mass: Reviewing the evidence to obtain management guidelines for intracranial meningiomas during pregnancy |
| Q37254730 | A rare cause of stroke in young adults: occlusion of the middle cerebral artery by a meningioma postpartum. |
| Q37434663 | Advances in meningioma therapy |
| Q46431698 | Anesthesiological aspects and complications of intracranial meningiomas operated at the Sylvanus Olympio University Hospital Center, Lomé: about 21 cases |
| Q36947867 | Association of tamoxifen with meningioma: a population-based study in Sweden |
| Q35914637 | Birth desires and intentions of women diagnosed with a meningioma |
| Q37848121 | Brain tumors and hormonal factors: review of the epidemiological literature |
| Q28269115 | Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study |
| Q38053441 | Chemotherapy: What is its role in meningioma? |
| Q36731580 | Cigarette smoking and risk of meningioma: the effect of gender |
| Q38993017 | Clinical Features, Radiologic Findings, and Surgical Outcomes of 65 Intracranial Psammomatous Meningiomas |
| Q57319766 | Comprehensive Analysis of DNA Repair Gene Variants and Risk of Meningioma |
| Q37134129 | Constitutional aneuploidy and cancer predisposition |
| Q35283987 | Endogenous and exogenous hormone exposure and the risk of meningioma in men. |
| Q34154936 | Epidemiology and etiology of meningioma |
| Q35619691 | Family and personal medical history and risk of meningioma |
| Q37293329 | Foster Kennedy Syndrome Due to Meningioma Growth during Pregnancy |
| Q37209917 | Gender and sex hormones in multiple sclerosis pathology and therapy. |
| Q82863415 | Hormonal effect on meningioma growth |
| Q39413493 | Hormone replacement therapy and risk of meningioma in women: a meta-analysis |
| Q88296770 | Houdini Tumor: Case Report and Literature Review of Pregnancy-Associated Meningioma |
| Q35205744 | Hunting for the causes of meningioma--obesity is a suspect |
| Q53395214 | Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy. |
| Q38233448 | Medical management of meningiomas |
| Q37785808 | Medical therapies for meningiomas |
| Q37939997 | Medical treatment of recurrent meningiomas |
| Q61445565 | Mendelian randomization provides support for obesity as a risk factor for meningioma |
| Q82863409 | Meningioma-toward an improved understanding of the role of sex steroids in tumor development and progression |
| Q39192189 | Meningiomas in pregnancy: timing of surgery and clinical outcomes as observed in 104 cases and establishment of a best management strategy |
| Q39682528 | Molecular and genetic characterization of meningiomas: future predictive assays and "personalized" treatment |
| Q55314608 | Multiple meningiomas in two male-to-female transsexual patients with hormone replacement therapy: A report of two cases and a brief literature review. |
| Q64102900 | Neurofibromatosis type 2 gene mutation and progesterone receptor messenger RNA expression in the pathogenesis of sporadic orbitocranial meningioma |
| Q23911230 | Occupational exposure to pesticides and risk of adult brain tumors |
| Q35842811 | Our experience of intracranial meningioma in Dakar: about 50 cases |
| Q38936466 | Pediatric infratentorial meningiomas: a series of 19 cases and review of the literature |
| Q50224681 | Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma. |
| Q42919803 | Regression of meningiomas after discontinuation of cyproterone acetate in a transsexual patient |
| Q104286917 | Relationship Between Oral Contraceptives and The Risk of Gliomas and Meningiomas :A Dose-response Meta-analysis and Systematic Review |
| Q35170369 | Risk factors for meningioma in postmenopausal women: results from the Iowa Women's Health Study |
| Q38218704 | Sex disparities in neuro-ophthalmologic disorders |
| Q45388824 | Spinal meningioma in childhood: clinical features and treatment |
| Q31029258 | Spontaneous resolution of visual loss due to optic pathway meningioma: A case report and a review of the literature. |
| Q30397712 | Temporal bone meningioma involving the middle ear: A case report |
| Q34270420 | The relationship between urinary bisphenol A levels and meningioma in Chinese adults |
| Q38867525 | Unique features of pregnancy-related meningiomas: lessons learned from 148 reported cases and theoretical implications of a prolactin modulated pathogenesis |
Search more.